Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03768284 · ClinicalTrials.gov registry record
Genetic Analysis of Pediatric Psoriasis
A clinical trial of Psoriasis, sponsored by Northwestern University.
- Completed
- Registry status
- 86
- Enrollment target
- 1
- Study location
NCT03768284: Completed study of Psoriasis, sponsored by Northwestern University.
NCT03768284 is a study of Psoriasis that has completed, run by Northwestern University. The registered enrollment target is 86 participants, below the 488-participant average among 125 other Psoriasis trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03768284, a study of Psoriasis, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will ascertain approximately 150 subjects, which will include pediatric psoriasis patients diagnosed before age 12, parents not affected by psoriasis, and if a family history is indicated, up to third-degree family members. Saliva (or buccal swabs in the case of infants) will be obtained for DNA isolation.
Primary Outcome
The number of pathogenic mutations identified in CARD14 in a pediatric psoriasis cohort
Conditions Studied
Interventions
- OTHER Saliva or buccal sample
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2018-10-17 |
| Est. Completion | 2021-12-30 |
What the finished NCT03768284 record still lists
NCT03768284 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 488-participant average among 125 other Psoriasis trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Psoriasis appearing as the primary indexed condition, and to 1 intervention - of which Saliva or buccal sample is the first listed.
NCT03768284 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03768284 about?
NCT03768284 is a clinical study titled "Genetic Analysis of Pediatric Psoriasis". This study will ascertain approximately 150 subjects, which will include pediatric psoriasis patients diagnosed before age 12, parents not affected by psoriasis, and if a family history is indicated, up to third-degree family members. Saliva (or buccal swabs in the case of infants) will be obtained ...
What is the current status of trial NCT03768284?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2018-10-17. Estimated completion is 2021-12-30.
What conditions does trial NCT03768284 study?
This clinical trial studies the following conditions: Psoriasis.
What interventions are being tested in trial NCT03768284?
The interventions under investigation include: Saliva or buccal sample (OTHER).
Who is sponsoring clinical trial NCT03768284?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03768284 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03768284's enrollment target sits among peer trials
86 62nd of 125 higher than 64 of 125 other Psoriasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psoriasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
RECRUITING · NA
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
Duobrii in Combination With Biologics
RECRUITING · Phase 4
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI